Regulation of B cell apoptosis by Bcl-2 and Bcl-XL and its role in the development of autoimmune diseases (Review).
- Authors:
- Published online on: February 1, 1998 https://doi.org/10.3892/ijmm.1.2.475
- Pages: 475-558
Metrics: Total
Views: 195 (Spandidos Publications: 195 | PMC Statistics: 0 )
Total PDF Downloads: 318 (Spandidos Publications: 318 | PMC Statistics: 0 )
Abstract
Cell death is a common event during B cell development. The demise of developing B cells is a regulated process that serves to select cell populations bearing functional receptors and to remove cells that are no longer needed or potentially autoreactive. Bcl-2 and Bcl-XL, two members of the bcl-2 gene family of programmed cell death regulators with anti-apoptotic activity, are expressed in a highly regulated pattern during B cell maturation. Overexpression of Bcl-2 in developing B cells of transgenic mice, in the presence of T cell dependent costimulatory signals, results in the generation of a modified B cell repertoire and in the production of pathogenic autoantibodies. While disregulation of programmed cell death in B cells may cause autoimmune manifestations in mice, the involvement of such alterations in the pathogenesis of autoimmune diseases in humans merits further investigation.
Related Articles
- Impaired thymopoiesis occurring during the thymic involution of tumor-bearing mice is associated with a down-regulation of the antiapoptotic proteins Bcl-XL and A1
- Bcl‑2/Bcl‑xL inhibitor ABT‑737 sensitizes pancreatic ductal adenocarcinoma to paclitaxel‑induced cell death
- Host H-2 haplotype modulates the induction of host-versus-graft disease after the induction of neonatal tolerance to H-2 alloantigens.
- Let‑7b binding site polymorphism in the B‑cell lymphoma‑extra large 3'UTR is associated with fluorouracil resistance of hepatocellular carcinoma
- Downregulation of the expression of B‑cell lymphoma‑extra large by RNA interference induces apoptosis and enhances the radiosensitivity of non‑small cell lung cancer cells